← All diseases Brain and nervous system

Progressive supranuclear palsy (PSP)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (31)Meta-analysis (11)Systematic review (13)Phase 3 study (4)Randomized Controlled Trial (3)Clinical trial (188)Review article (154)Early study (phase 1 or 2) (11)Single patient description (77)Laboratory or animal study (6)Commentary or editorial (51) Studies currently recruiting participants only (32)

Filter

Publications and studies (1196)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY (2021-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography. (2021-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis (2021-06-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) (2021-05-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease (2021-05-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms (2021-05-12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy (2021-04-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Brain Network Activation in Patients With Movement Disorders (2021-03-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA) (2021-03-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP) (2021-02-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP) (2021-02-03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Parkinson's disease and it's look-alike]. (2020/12/26) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: LRP1 Is a Master Regulator of Tau Uptake and Spread. (2020/12/23) ♡
• Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial. (2020/12/21) ♡
• Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease. (2020/12/17) ♡
• Signal intensity of cerebral gyri in corticobasal syndrome on phase difference enhanced magnetic resonance images: Comparison of progressive supranuclear palsy and Parkinson's disease. (2020/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Western Pacific ALS-PDC: Evidence implicating cycad genotoxins. (2020/12/15) ♡
• Clinical and Electrophysiological Hints to TMS in De Novo Patients with Parkinson's Disease and Progressive Supranuclear Palsy. (2020/12/12) ♡
• Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy. (2020/12/11) ♡
• REM sleep behavior in Parkinson disease: Frequent, particularly with higher age. (2020/12/07) ♡
• MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features. (2020/12/07) ♡
• GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition. (2020/12/05) ♡
• 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. (2020/12/05) ♡
• Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy. (2020/12/01) ♡
• Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R. (2020/12/01) ♡
• Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias. (2020/12/01) ♡
• Characterization of tau binding by gosuranemab. (2020/12/01) ♡
• Diagnostic Performance of (123)I-FPCIT SPECT Specific Binding Ratio in Progressive Supranuclear Palsy: Use of Core Clinical Features and MRI for Comparison. (2020/12/01) ♡
• How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders? (2020/12/01) ♡
• The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. (2020/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The "round the houses" sign and "zig-zag" sign in progressive supranuclear palsy and other conditions. (2020/12/01) ♡
• Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter. (2020/12/01) ♡
• Gait improvement after levofloxacin administration in a progressive supranuclear palsy patient. (2020/11/29) ♡
• Neural correlates of naming errors across different neurodegenerative diseases: An FDG-PET study. (2020/11/17) ♡
• Tau Pathology Drives Dementia Risk-Associated Gene Networks toward Chronic Inflammatory States and Immunosuppression. (2020/11/17) ♡
• Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy. (2020/11/16) ♡
• Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy. (2020/11/12) ♡
• (18)F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty. (2020/11/10) ♡
• Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies. (2020/11/04) ♡
• Social Cognition Deficits Are Pervasive across Both Classical and Overlap Frontotemporal Dementia Syndromes. (2020/11/04) ♡
• Japanese Familial Cases of Frontotemporal Dementia and Parkinsonism with N279K Tau Gene Mutation. (2020/11/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tau at the interface between neurodegeneration and neuroinflammation. (2020/11/01) ♡
• The diagnostic potential of multimodal neuroimaging measures in Parkinson's disease and atypical parkinsonism. (2020/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. What is causing this patient's balance and speech problems? (2020/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. (2020/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: 'Letter to the Editor on "Copathology Progressive Supranuclear Palsy: Does It Matter?"'. (2020/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "MRI Linear Measurements in Normal Pressure Hydrocephalus Versus Progressive Supranuclear Palsy". (2020/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor on "Copathology in Progressive Supranuclear Palsy: Does It Matter?". (2020/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. MRI Linear Measurements in Normal Pressure Hydrocephalus Versus Progressive Supranuclear Palsy. (2020/11/01) ♡
• Neurovestibular Dysfunction and Falls in Parkinson's Disease and Atypical Parkinsonism: A Prospective 1 Year Follow-Up Study. (2020/10/29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.